References of "Zhang, Yingying"
     in
Bookmark and Share    
Full Text
See detailIndividualised prediction of drug resistance and seizure recurrence after medication withdrawal in people with juvenile myoclonic epilepsy: A systematic review and individual participant data meta-analysis
Stevelink, Remi; Al-Toma, Dania; Jansen, Floor E. et al

in eClinicalMedicine (2022)

Summary Background A third of people with juvenile myoclonic epilepsy (JME) are drug-resistant. Three-quarters have a seizure relapse when attempting to withdraw anti-seizure medication (ASM) after ... [more ▼]

Summary Background A third of people with juvenile myoclonic epilepsy (JME) are drug-resistant. Three-quarters have a seizure relapse when attempting to withdraw anti-seizure medication (ASM) after achieving seizure-freedom. It is currently impossible to predict who is likely to become drug-resistant and safely withdraw treatment. We aimed to identify predictors of drug resistance and seizure recurrence to allow for individualised prediction of treatment outcomes in people with JME. Methods We performed an individual participant data (IPD) meta-analysis based on a systematic search in EMBASE and PubMed – last updated on March 11, 2021 – including prospective and retrospective observational studies reporting on treatment outcomes of people diagnosed with JME and available seizure outcome data after a minimum one-year follow-up. We invited authors to share standardised IPD to identify predictors of drug resistance using multivariable logistic regression. We excluded pseudo-resistant individuals. A subset who attempted to withdraw ASM was included in a multivariable proportional hazards analysis on seizure recurrence after ASM withdrawal. The study was registered at the Open Science Framework (OSF; https://osf.io/b9zjc/). Findings  368) was predicted by an earlier age at the start of withdrawal, shorter seizure-free interval and more currently used ASMs, resulting in an average internal-external cross-validation concordance-statistic of 0·70 (95%CI 0·68–0·73). Interpretation We were able to predict and validate clinically relevant personalised treatment outcomes for people with JME. Individualised predictions are accessible as nomograms and web-based tools. Funding MING fonds. [less ▲]

Detailed reference viewed: 24 (0 UL)
Full Text
Peer Reviewed
See detailHabenula deep brain stimulation for refractory bipolar disorder.
Zhang, Chencheng; Kim, Seung-Goo; Li, Dianyou et al

in Brain stimulation (2019)

Bipolar disorder (BD) is a mood disorder associated with significant morbidity and mortality. In many cases, BD can be managed with pharmacotherapy, psychological therapy, or electroconvulsive therapy [1 ... [more ▼]

Bipolar disorder (BD) is a mood disorder associated with significant morbidity and mortality. In many cases, BD can be managed with pharmacotherapy, psychological therapy, or electroconvulsive therapy [1]. For some afflicted patients, however, BD is a chronic and severely disabling condition that is resistant to the aforementioned treatments. Deep brain stimulation (DBS) offers a safe and effective neurosurgical treatment for otherwise refractory movement disorders and obsessive-compulsive disorder [2,3]. [less ▲]

Detailed reference viewed: 114 (2 UL)